Changsha, Jiangsu, China The main office of represented Corporate Investor is situated in the Changsha. The fund was located in Asia if to be more exact in China.
The standard case for the fund is to invest in rounds with 1 partaker. Despite the Aier Eye Hospital Group, startups are often financed by Trustbridge Partners, Sequoia Capital China, Redpoint.
Besides, a startup needs to be aged 11-15 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Qihoo 360 Technology. Among the most popular fund investment industries, there are Mobile, Internet. For fund there is a match between the country of its foundation and the country of its the most frequent investments - China.
The high activity for fund was in 2016. The increased amount of exits for fund were in 2011. Deals in the range of 10 - 50 millions dollars are the general things for fund. The fund is constantly included in less than 2 investment rounds annually.
The overall number of key employees were 2.
Related Funds
| Fund Name | Location |
| 100X.VC | India, Maharashtra, Mumbai |
| ACA Partners | - |
| Cardworks | New York, United States, Woodbury |
| Cleantech Open Northeast | Boston, Massachusetts, United States |
| Contango Asset Management | - |
| Counterpoint Global | - |
| Enlaces | Distrito Nacional, Dominican Republic, Santo Domingo |
| Gardiner Group Capital | Canada, Ontario, Toronto |
| Huohua Venture Capital | Anhui, China, Xuancheng |
| Lian Jijin | Beijing, Beijing, China |
| LPC Ventures | California, Los Angeles, United States |
| Merah Putih | Indonesia, Jakarta Raya, Slipi |
| National Institute of Standards and Technology | Gaithersburg, Maryland, United States |
| New Zealand Venture Investment Fund | Auckland, Auckland, New Zealand |
| Next Wave Partners | England, London, United Kingdom |
| Research Frontiers | New York, United States, Woodbury |
| Sandalwood Partners | Bangalore, India, Karnataka |
| Solus Capital | Budapest, Hungary |
| Virgin America | Burlingame, California, United States |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Sieran Medical | $15M | 05 Sep 2024 | Suzhou, Jiangsu, China | ||
Svision | $46M | 09 Mar 2023 | Huizhou, Guangdong Province, China | ||
SIYO Bio-Tech | $30M | 23 Feb 2022 | Beijing, Beijing, China | ||
Zhaoke Ophthalmology Pharmaceutical | $145M | 12 Oct 2020 | Hong Kong Island, Hong Kong | ||
CloudClip | $1M | 31 Dec 2016 | China, Zhejiang |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Sieran Medical | $15M | 05 Sep 2024 | Suzhou, Jiangsu, China | ||
Svision | $46M | 09 Mar 2023 | Huizhou, Guangdong Province, China | ||
SIYO Bio-Tech | $30M | 23 Feb 2022 | Beijing, Beijing, China | ||
Zhaoke Ophthalmology Pharmaceutical | $145M | 12 Oct 2020 | Hong Kong Island, Hong Kong | ||
CloudClip | $1M | 31 Dec 2016 | China, Zhejiang |
